These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11153141)

  • 1. Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis.
    Zimra Y; Nudelman A; Zhuk R; Rabizadeh E; Shaklai M; Aviram A; Rephaeli A
    J Cancer Res Clin Oncol; 2000 Dec; 126(12):693-8. PubMed ID: 11153141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esterase inhibitors diminish the modulation of gene expression by butyric acid derivative, pivaloyloxymethyl butyrate (AN-9).
    Rabizadeh E; Shaklai M; Eisenbach L; Nudelman A; Rephaeli A
    Isr J Med Sci; 1996 Dec; 32(12):1186-91. PubMed ID: 9007151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug.
    Rabizadeh E; Shaklai M; Nudelman A; Eisenbach L; Rephaeli A
    FEBS Lett; 1993 Aug; 328(3):225-9. PubMed ID: 8348968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line.
    Aviram A; Zimrah Y; Shaklai M; Nudelman A; Rephaeli A
    Int J Cancer; 1994 Mar; 56(6):906-9. PubMed ID: 8119779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrug modification increases potassium tricyclo[5.2.1.0(2,6)]-decan-8-yl dithiocarbonate (D609) chemical stability and cytotoxicity against U937 leukemia cells.
    Bai A; Meier GP; Wang Y; Luberto C; Hannun YA; Zhou D
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1051-9. PubMed ID: 14960662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity.
    Nudelman A; Rephaeli A
    J Med Chem; 2000 Jul; 43(15):2962-6. PubMed ID: 10956204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of intracellularly released formaldehyde and butyric acid in the anticancer activity of acyloxyalkyl esters.
    Nudelman A; Levovich I; Cutts SM; Phillips DR; Rephaeli A
    J Med Chem; 2005 Feb; 48(4):1042-54. PubMed ID: 15715472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases.
    Dolan ME; Roy SK; Garbiras BJ; Helft P; Paras P; Chae MY; Moschel RC; Pegg AE
    Biochem Pharmacol; 1998 May; 55(10):1701-9. PubMed ID: 9634007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
    Chen ZX; Breitman TR
    Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells.
    Zimra Y; Wasserman L; Maron L; Shaklai M; Nudelman A; Rephaeli A
    J Cancer Res Clin Oncol; 1997; 123(3):152-60. PubMed ID: 9119880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Butyrate Prodrug Pivaloyloxymethyl Butyrate (AN9) on a Mouse Model for Spinal Muscular Atrophy.
    Edwards JD; Butchbach ME
    J Neuromuscul Dis; 2016 Nov; 3(4):511-515. PubMed ID: 27911337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9).
    Cutts SM; Rephaeli A; Nudelman A; Hmelnitsky I; Phillips DR
    Cancer Res; 2001 Nov; 61(22):8194-202. PubMed ID: 11719450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anticancer prodrugs of butyric acid. 2.
    Nudelman A; Ruse M; Aviram A; Rabizadeh E; Shaklai M; Zimrah Y; Rephaeli A
    J Med Chem; 1992 Feb; 35(4):687-94. PubMed ID: 1542095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of esterases involved in the hydrolysis of dipivefrin hydrochloride.
    Nakamura M; Shirasawa E; Hikida M
    Ophthalmic Res; 1993; 25(1):46-51. PubMed ID: 8446367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of oxymethyl-modified coumarinic acid cyclic prodrugs of diastereomeric opioid peptides in biological media from various animal species including human.
    Liederer BM; Borchardt RT
    J Pharm Sci; 2005 Oct; 94(10):2198-206. PubMed ID: 16136552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units.
    Siu LL; Von Hoff DD; Rephaeli A; Izbicka E; Cerna C; Gomez L; Rowinsky EK; Eckhardt SG
    Invest New Drugs; 1998; 16(2):113-9. PubMed ID: 9848574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells.
    Aviram A; Rephaeli A; Shaklai M; Nudelman A; Ben-Dror I; Maron L; Rabizadeh E
    J Cancer Res Clin Oncol; 1997; 123(5):267-71. PubMed ID: 9201249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor evaluation of bis[(pivaloyloxy)methyl] 2'-deoxy-5-fluorouridine 5'-monophosphate (FdUMP): a strategy to introduce nucleotides into cells.
    Farquhar D; Khan S; Srivastva DN; Saunders PP
    J Med Chem; 1994 Nov; 37(23):3902-9. PubMed ID: 7966151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species dependent esterase activities for hydrolysis of an anti-HIV prodrug glycovir and bioavailability of active SC-48334.
    Cook CS; Karabatsos PJ; Schoenhard GL; Karim A
    Pharm Res; 1995 Aug; 12(8):1158-64. PubMed ID: 7494828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selectivty and anti-metastatic activity of oral bioavailable butyric acid prodrugs.
    Rephaeli A; Entin-Meer M; Angel D; Tarasenko N; Gruss-Fischer T; Bruachman I; Phillips DR; Cutts SM; Haas-Kogan D; Nudelman A
    Invest New Drugs; 2006 Sep; 24(5):383-92. PubMed ID: 16502348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.